Caio H N Barros, Manuel Alfaro, Agota Csiki-Fejer, Bakul Bhatnagar, Serguei Tschessalov, Steven Ferguson, Sutapa Barua, Ramin Darvari, Elizabeth M Topp
{"title":"用色谱和电泳方法比较分析mRNA降解动力学。","authors":"Caio H N Barros, Manuel Alfaro, Agota Csiki-Fejer, Bakul Bhatnagar, Serguei Tschessalov, Steven Ferguson, Sutapa Barua, Ramin Darvari, Elizabeth M Topp","doi":"10.1021/acs.molpharmaceut.4c01543","DOIUrl":null,"url":null,"abstract":"<p><p>The effects of temperature and lipid nanoparticle (LNP) encapsulation on mRNA chemical stability were assessed for two model mRNA (EGFP mRNA, 996 nt; Fluc mRNA, 1929 nt) using capillary electrophoresis (CE) and ion pair reversed phase high performance liquid chromatography (IP-RP-HPLC) to measure mRNA integrity. The apparent degradation rates for unencapsulated (\"naked\") mRNA were method-dependent for Fluc mRNA, with rates up to 50% greater when measured using CE compared to IP-RP-HPLC. This discrepancy is attributed to differences in mass resolution, separation mechanisms and/or linearity of the two methods and was not observed for EGFP mRNA. The apparent reaction order for naked mRNA degradation varied with storage temperature, being zero-order at 35 °C and first-order at 50 °C. Encapsulation of mRNA using LNPs slowed mRNA degradation by up to 9-fold relative to naked mRNA controls stored under the same conditions. Encapsulation also induced changes in thermal unfolding patterns. Overall, the results show the benefits and limitations of each analytical method for determining mRNA degradation kinetics and the effects of temperature and LNP encapsulation on mRNA stability.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":" ","pages":"3061-3072"},"PeriodicalIF":4.5000,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparative Analysis of mRNA Degradation Kinetics Using Chromatographic and Electrophoretic Methods.\",\"authors\":\"Caio H N Barros, Manuel Alfaro, Agota Csiki-Fejer, Bakul Bhatnagar, Serguei Tschessalov, Steven Ferguson, Sutapa Barua, Ramin Darvari, Elizabeth M Topp\",\"doi\":\"10.1021/acs.molpharmaceut.4c01543\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The effects of temperature and lipid nanoparticle (LNP) encapsulation on mRNA chemical stability were assessed for two model mRNA (EGFP mRNA, 996 nt; Fluc mRNA, 1929 nt) using capillary electrophoresis (CE) and ion pair reversed phase high performance liquid chromatography (IP-RP-HPLC) to measure mRNA integrity. The apparent degradation rates for unencapsulated (\\\"naked\\\") mRNA were method-dependent for Fluc mRNA, with rates up to 50% greater when measured using CE compared to IP-RP-HPLC. This discrepancy is attributed to differences in mass resolution, separation mechanisms and/or linearity of the two methods and was not observed for EGFP mRNA. The apparent reaction order for naked mRNA degradation varied with storage temperature, being zero-order at 35 °C and first-order at 50 °C. Encapsulation of mRNA using LNPs slowed mRNA degradation by up to 9-fold relative to naked mRNA controls stored under the same conditions. Encapsulation also induced changes in thermal unfolding patterns. Overall, the results show the benefits and limitations of each analytical method for determining mRNA degradation kinetics and the effects of temperature and LNP encapsulation on mRNA stability.</p>\",\"PeriodicalId\":52,\"journal\":{\"name\":\"Molecular Pharmaceutics\",\"volume\":\" \",\"pages\":\"3061-3072\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-06-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Pharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1021/acs.molpharmaceut.4c01543\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/5/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.molpharmaceut.4c01543","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/18 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Comparative Analysis of mRNA Degradation Kinetics Using Chromatographic and Electrophoretic Methods.
The effects of temperature and lipid nanoparticle (LNP) encapsulation on mRNA chemical stability were assessed for two model mRNA (EGFP mRNA, 996 nt; Fluc mRNA, 1929 nt) using capillary electrophoresis (CE) and ion pair reversed phase high performance liquid chromatography (IP-RP-HPLC) to measure mRNA integrity. The apparent degradation rates for unencapsulated ("naked") mRNA were method-dependent for Fluc mRNA, with rates up to 50% greater when measured using CE compared to IP-RP-HPLC. This discrepancy is attributed to differences in mass resolution, separation mechanisms and/or linearity of the two methods and was not observed for EGFP mRNA. The apparent reaction order for naked mRNA degradation varied with storage temperature, being zero-order at 35 °C and first-order at 50 °C. Encapsulation of mRNA using LNPs slowed mRNA degradation by up to 9-fold relative to naked mRNA controls stored under the same conditions. Encapsulation also induced changes in thermal unfolding patterns. Overall, the results show the benefits and limitations of each analytical method for determining mRNA degradation kinetics and the effects of temperature and LNP encapsulation on mRNA stability.
期刊介绍：
Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development.
Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
